New diabetes drug PATAS takes first step in human safety trial
NCT ID NCT07223333
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 33 times
Summary
This early-stage study tests whether a new drug called PATAS is safe for people. It involves 56 healthy volunteers who receive either the drug or a placebo. The main goal is to check for side effects and measure how the drug moves through the body. This is a first step before testing in people with type 2 diabetes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Medpace Clinical Pharmacology Unit
RECRUITINGCincinnati, Ohio, 45227, United States
Contact
-
Medpace Clinical Pharmaology Unit
RECRUITINGCincinnati, Ohio, 45227, United States
Conditions
Explore the condition pages connected to this study.